
State government is using its purchasing power to help residents save on the cost of insulin, regardless of their insurance status. All consumers have to do is access an ID card to start saving.
“This is what a big purchaser can accomplish when the primary motivation is not profit but the public health of the people of the state of Connecticut,” Comptroller Kevin Lembo said Tuesday.
Lembo administers the state health plan, which serves more than 200,000 state and municipal employees, retirees and dependents. The initiative stemmed from discussions with the pharmaceutical industry about chipping away at the costs of medication in the interest of wellness, regardless of insurance status. Insulin seemed to be a good place to start, Lembo said.
The State of Connecticut Drug Discount Program, announced in partnership with CVS Caremark early last month, allows any Connecticut resident, regardless of insurance status, to save on the price of some types of insulin by more than $100.
For example, a 10 ml vial of Novolin R may be available at a Wal-Mart for $25. But if that store is far away, the same prescription might cost as much as $137 at another pharmacy. With a program card, the price would be $25.
Certain forms of Novo Nordisk insulin are available through the program at 50% less than the retail price.
“It can be heartbreaking for the pharmacist when someone shows up and doesn’t have the $250 to pay for the medication,” Lembo said.
State Rep. Eleni Kavros DeGraw, who sits on the Public Health Committee, said this program is big news for those living with diabetes. Kavros DeGraw said people who may not be able to afford insulin might skip a dose here or there because they can’t afford the medication.
“This isn’t like skipping Tylenol for a headache,” Kavros DeGraw said. Making sure residents have the medication they need can be the difference between life and death, and prevent long-term health issues, thereby saving on medical costs down the road, she added.
“The fact is, this is going to address the rising cost of insulin, which has been around for a very long time, and yet we continue to see the costs rising,” Kavros DeGraw said.
The Avon Democrat said her constituents often voice concerns to her about the rising cost of prescription medications, not just insulin.
Support authentic, locally owned and operated public service journalism!
Lembo said his office will see how this program does with the insulin first, and then will start the work to add on more medications to the discount list.
Residents can go online and create a personalized discount card to access the discounts at a wide variety of network pharmacies. Participants must show their discount cards when purchasing the medications. A list of the discounted medications is available here.
More Health Care News & Analysis

AG’s Tackle Mental Health Parity
Attorneys General in Connecticut and Rhode Island threw their support Monday behind a coalition of mental health advocacy groups asking a federal appeals court to revisit a recent ruling giving insurance companies more flexibility to deny mental health claims. In late March, a three-judge panel in the California-based 9th U.S. Court of Appeals reversed a…
Keep reading
Budget Green Lights Psychedelic Therapies
Buried in the budget Gov. Ned Lamont signed this week is a provision that would create a pilot program to allow Connecticut to be the first-in-the-nation to study the impact of psychedelic drugs like psilocybin and MDMA on patients with depression and PTSD. The budget now creates a pilot program within the Department of Mental…
Keep reading
Officials Highlight Effort To Boost Mental Health Services For Kids
At a Hartford-based community provider Wednesday, Gov. Ned Lamont and a handful of his agency commissioners highlighted the expected impact of more than $100 million in recently passed funding aimed at increasing behavioral health services for Connecticut children. The governor appeared at The Village for Families and Children, a recipient of new state funding included…
Keep reading
Democrats Turn Focus To Roe v. Wade
With the legislative session and the conventions in the rearview mirror, Democrats in Connecticut are turning their focus to the U.S. Senate and the upcoming vote to codify Roe v. Wade and the impact it could have on the 2022 Elections. U.S. Sen. Chris Murphy was on Fox News Sunday talking about the issue, which…
Keep reading
OP-ED | Policymakers Did Little to Lower Healthcare Costs This Session
Last year, Connecticut policymakers accomplished little to reduce the cost of healthcare, and those costs haven’t gotten any better since then. Incumbents will be asked what they did this year to provide some relief. Unfortunately, they have little to offer.
Keep reading
ANALYSIS | Will the 2022 Legislative Session Help or Hurt Democrats in the Fall?
The short but surprisingly productive 2022 session of the General Assembly is coming to a close this week. As Democrats race to pass bills, and Republicans do all they can to talk them to death, a question that has to be on the minds of a lot of legislators is what the session means, if…
Keep reading